A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide.
about
Efficient intracellular gene delivery using the formulation composed of poly (L-glutamic acid) grafted polyethylenimine and histone.Characterization of polyethylenimine by electrospray ionization and matrix-assisted laser desorption/ionization.Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.Visualizing the attack of RNase enzymes on dendriplexes and naked RNA using atomic force microscopy.Polycation gene delivery systems: escape from endosomes to cytosol.Polymeric core-shell nanoparticles for therapeutics.Emerging vectors and targeting methods for nonviral gene therapy.pH-responsive shielding of non-viral gene vectors.Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and NucleusBalancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivoState-of-the-art analytical methods for assessing dynamic bonding soft matter materials.Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.Nanomedicine for gene therapy.Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.Peptide-Based and Polypeptide-Based Gene Delivery Systems.Functional peptides for siRNA delivery.Modification of calcium carbonate based gene and drug delivery systems by a cell-penetrating peptide.Modified polyethyleneimine with histidine-lysine short peptides as gene carrier.Polyethylenimine-mediated gene delivery to the lung and therapeutic applications.Synthetic PEGylated glycoproteins and their utility in gene delivery.PEG stabilized DNA - poly(ferrocenylsilane) polyplexes for gene delivery.An improved large-scale synthesis of PEG-peptides for gene delivery.Nanoparticles Escaping RES and Endosome: Challenges for siRNA Delivery for Cancer Therapy
P2860
Q33772608-FE06DD9E-6B11-463B-81DC-2A19437BFB43Q34019309-428FBC06-F981-481A-B82C-B5629837CBB0Q34351307-AD6DFD9B-06E4-480F-8626-0D9E71F86B71Q34700581-2CC9DF59-E333-4C2F-AAEC-90AD1B64ACD9Q35169492-D2882A6B-D383-4139-9597-857CBB4790DAQ36478861-1A8DB151-460D-4A8C-A5D0-DE8DBA078DF0Q36580613-CDB8632B-D27F-4841-9D53-74D80FB9A561Q36583716-B0780146-4A57-47FB-BBC4-7E15D40FD9E1Q36689670-0827C258-B683-47E1-B21C-0F061063E89BQ37378292-25BAE5B4-E96A-418C-81A3-BB653489DEA2Q38208285-944CBE55-1D00-4332-A67B-9F682A1CA674Q38262399-4C02F66C-04F1-48F7-A2DB-AF07DA2747C3Q38383478-60FA76B2-6FE4-4511-B1CE-6E4FE2F00860Q38695286-DE829E2C-C505-4644-B40B-47E9B2A0BF21Q38747732-9F2969D1-E9C7-4555-8E1B-D9F9C6D22246Q38928987-7DF862E4-D231-44A1-A153-C2399A90D76DQ39255518-C676E22C-CA2B-428F-B034-1E2C267EDDFFQ39646936-404A9CDD-F742-42D1-A2A1-0310B981852FQ41985187-3011153A-B7C3-4B2D-B206-5D8E1108FFD9Q42174372-90FE2CAD-C8C6-4D3F-A25A-435A773B21DCQ46047962-14930224-B7D0-427D-9348-D95C0CFD7BD3Q53629044-9ACA585B-8A32-496B-92DD-B6D6FA18B2F9Q58691112-12AD81C7-8EF8-4E0D-ADB5-652591B692B3
P2860
A new gene delivery formulation of polyethylenimine/DNA complexes coated with PEG conjugated fusogenic peptide.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@ast
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@en
type
label
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@ast
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@en
prefLabel
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@ast
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@en
P2093
P1476
A new gene delivery formulatio ...... conjugated fusogenic peptide.
@en
P2093
P304
P356
10.1016/S0168-3659(01)00426-6
P407
P577
2001-09-01T00:00:00Z